Thromboplastin standards

Biologicals

Volumn 38, Issue 4, 2010, Pages 430-436

  van den Besselaar, A M H P ^a   Chantarangkul, V ^b   Tripodi, A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

International Normalized Ratio; Prothrombin Time; Standard; Thromboplastin; Vitamin K antagonist

Indexed keywords

ANTIVITAMIN K; THROMBOPLASTIN;

ANALYTICAL ERROR; CALIBRATION; CHRONIC LIVER DISEASE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROTEIN STABILITY; PROTHROMBIN TIME; REFERENCE VALUE; REVIEW; STANDARD; STANDARDIZATION; THERMOSTABILITY; WORLD HEALTH ORGANIZATION;

CALIBRATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; PROTHROMBIN TIME; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; THROMBOPLASTIN;

EID: 77955268964     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.02.012     Document Type: Review

References (54)

1. Hirsh J., Levine M. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America. Thromb Haemost 1988, 59:129-132.
2. Quick A.J., Stanley-Brown M., Bancroft F.W. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935, 190:501-511.
3. Poller L. The theory and practice of anticoagulant treatment 1962, John Wright & Sons Ltd, Bristol.
4. Owren P.A. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959, 2:754-758.
5. Loeliger E.A. Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation. Acta Haematol 1985, 74:125-131.
6. Biggs R., Denson K.W.E. Standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Br Med J 1967, 1:84-88.
7. Loeliger E.A. ICSH/ICTH Recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 1985, 54:155-156.
8. WHO Expert Committee on Biological Standardization Forty-eighth report. WHO Technical Report series, No. 889 1999, World Health Organization, Geneva, pp. 64-93.
9. WHO Expert Committee on Biological Standardization Twenty-eighth report. WHO Technical Report series, No. 610 1977, World Health Organization, Geneva, p. 14.
10. Kirkwood T.B.L. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983, 49:238-244.
11. WHO Expert Committee on Biological Standardization Thirty-third report. WHO Technical Report series, No. 687 1983, World Health Organization, Geneva, pp. 81-105.
12. Tomenson J.A. A statistician's independent evaluation. Thromboplastin calibration and oral anticoagulant control 1984, 87-108. Martinus Nijhoff Publishers, Boston. A.M.H.P. Van den Besselaar, H.R. Gralnick, S.M. Lewis (Eds.).
13. Van den Besselaar A.M.H.P., Bertina R.M. Multi-center study of thromboplastin calibration precision. Influence of reagent species, composition, and International Sensitivity Index (ISI). Thromb Haemost 1993, 69:35-40.
14. Bangham D.R., Biggs R., Brozović M., Denson K.W.E. Draft report of a collaborative study of two thromboplastins (including the use of common abnormal plasma). Thromb Diath Haemorrh 1970, (Suppl. 40):341-351.
15. Hermans J., van den Besselaar A.M.H.P., Loeliger E.A., van der Velde E.A. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemost 1983, 50:712-717.
16. Thomson J.M., Tomenson J.A., Poller L. The calibration of the second primary International Reference Preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253). Thromb Haemost 1984, 52:336-342.
17. Van den Besselaar A.M.H.P. Multi-center study of replacement of the International Reference Preparation for thromboplastin, rabbit, plain. Thromb Haemost 1993, 70:794-799.
18. Tripodi A., Chantarangkul V., Negri B., Clerici M., Mannucci P.M. International collaborative study for the calibration of a proposed Reference Preparation for thromboplastin, human recombinant, plain. Thromb Haemost 1998, 79:439-443.
19. Chantarangkul V., van den Besselaar A.M.H.P., Witteveen E., Tripodi A. International collaborative study for the calibration of a proposed International Standard for thromboplastin, rabbit, plain. J Thromb Haemost 2006, 4:1339-1345.
20. Van den Besselaar A.M.H.P., Tripodi A. Is there a need for replacement of the International Reference Preparation for thromboplastin, bovine, combined (OBT/79)?. J Thromb Haemost 2005, 3:2365-2366.
21. Van den Besselaar A.M.H.P., Houbouyan L.L., Aillaud M.F., Denson K.W.E., Johnston M., Kitchen S., et al. Influence of three types of automated coagulometers on the International Sensitivity Index (ISI) of rabbit, human, and recombinant human tissue factor preparations. Thromb Haemost 1999, 81:66-70.
22. Chantarangkul V., Tripodi A., Clerici M., Negri B., Mannucci P.M. Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost 1998, 80:258-262.
23. Van Geest-Daalderop J.H.H., Mulder A.B., Boonman-de Winter L.J.M., Hoekstra M.M.C.L., van den Besselaar A.M.H.P. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/International Normalized Ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005, 51:561-568.
24. Tripodi A., Chantarangkul V., Bressi C., Mannucci P.M. How to evaluate the influence of blood collection systems on the International Sensitivity Index. Protocol applied to two new evacuated tubes and eight coagulometer/thromboplastin combinations. Thromb Res 2003, 108:85-89.
25. Van den Besselaar A.M.H.P., Rutten W.P.F., Witteveen E. Effect of magnesium contamination in evacuated blood collection tubes on the prothrombin time test and ISI calibration using recombinant human thromboplastin and different types of coagulometer. Thromb Res 2005, 115:239-244.
26. Van den Besselaar A.M.H.P., Hoekstra M.M.C.L., Witteveen E., Didden J.H., van der Meer F.J.M. Influence of blood collection systems on the prothrombin time and International Sensitivity Index determined with human and rabbit thromboplastin reagents. Am J Clin Pathol 2007, 127:724-729.
27. Finney D.J. Calibration guidelines challenge outlier practices. Am Stat 2006, 60:309-314.
28. Webster P.S., Oleson F.B., Paterson D.L., Arkin C.F., Mangili A., Craven D.E., et al. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results. Blood Coagul Fibrinolysis 2008, 19:32-38.
29. Van den Besselaar A.M.H.P., Tripodi A. Effect of daptomycin on prothrombin time and the requirement for outlier exclusion in International Sensitivity Index calibration of thromboplastin. J Thromb Haemost 2007, 5:1975-1976.
30. Attermann J. Inaccuracy of International Normalized Ratio (INR) measurements and suggestions for improved WHO guidelines for calibration of reference preparations - a statistical study. J Thromb Haemost 2003, 1:537-544.
31. Finney D.J. Calibration of thromboplastins. Proc R Soc Lond B 1995, 262:71-75.
32. Van den Besselaar A.M.H.P., Hermans J., Beeser H., Loeliger E.A. Long-term stability of International Reference Preparations for thromboplastins. Br J Haematol 1988, 68:321-328.
33. Poller L., Pulford J., Stevenson K.J., Cooper P., Gamble G., Thomson J.M. Long-term stability studies on the WHO IRP for thromboplastin (human plain BCT/253). Thromb Haemost 1994, 72:682-684.
34. Linsinger T.P.J., van den Besselaar A.M.H.P., Tripodi A. Long-term stability of relationships between reference materials for thromboplastins. Thromb Haemost 2006, 96:210-214.
35. Van den Besselaar A.M.H.P., Tripodi A. A reassessment of the relationship between International Reference Preparations for human and rabbit thromboplastins. Thromb Haemost 2002, 88:459-461.
36. Poller L., Keown M., Chauhan N., van den Besselaar A.M.H.P., Tripodi A., Shiach C., et al. European concerted action on anticoagulation. A multicentre calibration study of WHO International Reference Preparations for thromboplastin, rabbit (RBT/90) and human (rTF/95). J Clin Pathol 2005, 58:667-669.
37. Van den Besselaar A.M.H.P., Witteveen E., Schaefer-van Mansfeld H., Meeuwisse-Braun J., Strebus A. Accelerated degradation test of lyophilized recombinant tissue factor-liposome preparations. Thromb Haemost 1995, 73:392-397.
38. Van den Besselaar A.M.H.P., van Rijn C.J.J., Taberner D.A., Goodman L.J., Poller L., Clarke K. Heat stability of two candidate International Reference Preparations for recombinant human tissue factor. Thromb Haemost 1997, 78:852-854.
39. Hubbard A.R., Margetts S.M.L., Weller L.J., Macnab J., Barrowcliffe T.W. An international collaborative study on the INR calibration of freeze-dried reference plasmas. Br J Haematol 1999, 104:455-460.
40. Van den Besselaar A.M.H.P., Barrowcliffe T.W., Houbouyan-Réveillard L.L., Jespersen J., Johnston M., Poller L., et al. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost 2004, 2:1946-1953.
41. Chantarangkul V., Frontini R., Gresele P., Oca G., Paniccia R., Pellegrini L., et al. Usefulness of lyophilized calibration plasmas for International Normalized Ratio determination with the bovine combined thromboplastin (Thrombotest): results of a collaborative study. Blood Coagul Fibrinolysis 2005, 16:157-163.
42. Van den Besselaar A.M.H.P., Houdijk W.P.M. Use of lyophilized calibrant plasmas for simplified International Normalized Ratio determination with a human tissue factor thromboplastin reagent derived from cultured human cells. Clin Chem 2003, 49:2006-2011.
43. Favaloro E.J., Hamdam S., McDonald J., McVicker W., Ule V. Time to think outside the box? Prothrombin time, International Normalised Ratio, International Sensitivity Index, mean normal prothrombin time and measurement of uncertainty: a novel approach to standardisation. Pathology 2008, 40:277-287.
44. Bland J.M., Altman D.G. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995, 346:1085-1087.
45. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. United Network for organ Sharing liver disease Severity score Committee. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology 2003, 124:91-96.
46. Trotter J.F., Brimhall B., Arjal R., Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004, 10:995-1000.
47. Robert A., Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or International Normalized Ratio?. Hepatology 1996, 24:1392-1394.
48. Kovacs M.J., Wong A., MacKinnon K., Weir K., Keeney M., Boyle E., et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 1994, 71:727-730.
49. Denson K.W., Reed S.V., Haddon M.E., Woodhams B., Brucato C., Ruiz J. Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res 1999, 94:255-261.
50. liver) Normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 2007, 46:520-527.
51. Bellest L., Eschwege V., Poupon R., Chazouillères O., Robert A. A modified International Normalized Ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 2007, 46:528-534.
52. liver for the calculation of the MELD score. J Hepatol 2009, 51:288-295.
53. Tripodi A., Chantarangkul V., Mannucci P.M. The International Normalized Ratio to prioritize patients for liver transplantation. Problems and possible solutions. J Thromb Haemost 2008, 6:243-248.
54. liver) for model of end-stage liver disease calculation. Hepatology 2008, 47:1423-1424.